MX2018001223A - Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla. - Google Patents
Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla.Info
- Publication number
- MX2018001223A MX2018001223A MX2018001223A MX2018001223A MX2018001223A MX 2018001223 A MX2018001223 A MX 2018001223A MX 2018001223 A MX2018001223 A MX 2018001223A MX 2018001223 A MX2018001223 A MX 2018001223A MX 2018001223 A MX2018001223 A MX 2018001223A
- Authority
- MX
- Mexico
- Prior art keywords
- preparing
- pharmaceutical composition
- same
- storage stability
- improved storage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20150106629 | 2015-07-28 | ||
| PCT/KR2016/008270 WO2017018820A1 (en) | 2015-07-28 | 2016-07-28 | Pharmaceutical composition with improved storage stability and method for preparing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2018001223A true MX2018001223A (es) | 2018-11-09 |
Family
ID=57884713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018001223A MX2018001223A (es) | 2015-07-28 | 2016-07-28 | Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP3328437A4 (zh) |
| JP (1) | JP2018521105A (zh) |
| KR (1) | KR101787453B1 (zh) |
| CN (1) | CN107466231A (zh) |
| AU (1) | AU2016299548A1 (zh) |
| BR (1) | BR112018001737A2 (zh) |
| CA (1) | CA2993928A1 (zh) |
| HK (1) | HK1249441A1 (zh) |
| IL (1) | IL257187A (zh) |
| MX (1) | MX2018001223A (zh) |
| RU (1) | RU2018107055A (zh) |
| WO (1) | WO2017018820A1 (zh) |
| ZA (1) | ZA201801187B (zh) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6020507A (en) | 1998-03-02 | 2000-02-01 | Bristol-Myers Squibb Company | Synthesis of paclitaxel from baccatin III by protection of the 7-hydroxyl of baccatin III using a strong base and an electrophile |
| EP1280557B1 (en) * | 2000-05-12 | 2012-06-20 | Samyang Corporation | Method for the preparation of polymeric micelle via phase separation of block copolymer |
| US7217770B2 (en) * | 2000-05-17 | 2007-05-15 | Samyang Corporation | Stable polymeric micelle-type drug composition and method for the preparation thereof |
| NZ532198A (en) * | 2001-10-18 | 2006-03-31 | Samyang Corp | Polymeric micelle composition of an amphiphilic block copolymer and a polylactic acid derivative |
| WO2005037840A1 (en) | 2003-10-16 | 2005-04-28 | Mayne Pharma (Usa), Inc. | Method for inverting the c2’ hydroxyl group of taxane esters |
| KR101024742B1 (ko) * | 2007-12-31 | 2011-03-24 | 주식회사 삼양사 | 탁산 함유 양친성 블록 공중합체 미셀 조성물 및 그 제조방법 |
| US9801818B2 (en) * | 2007-12-31 | 2017-10-31 | Samyang Biopharmaceuticals Corporation | Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug |
| RU2459840C2 (ru) * | 2007-12-31 | 2012-08-27 | Самъянг Корпорейшн | АМФИФИЛЬНЫЙ СОПОЛИМЕР ВЫСОКОЙ ЧИСТОТЫ, СОДЕРЖАЩИЙ ГИДРОФОБНЫЙ БЛОК ИЗ α-ГИДРОКСИКИСЛОТЫ, И СПОСОБ ЕГО ПОЛУЧЕНИЯ |
| EP2201935B1 (en) * | 2008-12-26 | 2020-07-08 | Samyang Biopharmaceuticals Corporation | Polymeric micelle composition containing a poorly soluble drug and preparation method of the same |
-
2016
- 2016-07-27 KR KR1020160095415A patent/KR101787453B1/ko active IP Right Grant
- 2016-07-28 MX MX2018001223A patent/MX2018001223A/es unknown
- 2016-07-28 CA CA2993928A patent/CA2993928A1/en not_active Abandoned
- 2016-07-28 EP EP16830853.4A patent/EP3328437A4/en not_active Withdrawn
- 2016-07-28 WO PCT/KR2016/008270 patent/WO2017018820A1/en active Application Filing
- 2016-07-28 JP JP2018504263A patent/JP2018521105A/ja active Pending
- 2016-07-28 CN CN201680001947.1A patent/CN107466231A/zh active Pending
- 2016-07-28 RU RU2018107055A patent/RU2018107055A/ru unknown
- 2016-07-28 AU AU2016299548A patent/AU2016299548A1/en not_active Abandoned
- 2016-07-28 BR BR112018001737A patent/BR112018001737A2/pt not_active Application Discontinuation
-
2018
- 2018-01-28 IL IL257187A patent/IL257187A/en unknown
- 2018-02-21 ZA ZA2018/01187A patent/ZA201801187B/en unknown
- 2018-07-13 HK HK18109126.8A patent/HK1249441A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1249441A1 (zh) | 2018-11-02 |
| RU2018107055A3 (zh) | 2019-08-28 |
| CN107466231A (zh) | 2017-12-12 |
| RU2018107055A (ru) | 2019-08-28 |
| JP2018521105A (ja) | 2018-08-02 |
| KR20170015200A (ko) | 2017-02-08 |
| WO2017018820A1 (en) | 2017-02-02 |
| CA2993928A1 (en) | 2017-02-02 |
| BR112018001737A2 (pt) | 2018-09-11 |
| AU2016299548A1 (en) | 2018-02-22 |
| IL257187A (en) | 2018-03-29 |
| EP3328437A1 (en) | 2018-06-06 |
| KR101787453B1 (ko) | 2017-10-19 |
| ZA201801187B (en) | 2018-12-19 |
| EP3328437A4 (en) | 2019-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3523419A4 (en) | COMPOSITIONS AND METHODS FOR PRESERVING CELL VITABILITY | |
| MY193806A (en) | Affinity-oligonucleotide conjugates and uses thereof | |
| EP3285711A4 (en) | Anaerobic blood storage containers | |
| EP3118195A4 (en) | Production method for episulfide compound for optical material, episulfide-containing composition, and polymerizable composition including episulfide-containing composition and for use in optical material | |
| IL241046A0 (en) | Fertilizer composition and method for its preparation | |
| EP3219650A4 (en) | Double-weighing metering storage hopper | |
| EP3130355A4 (en) | Pharmaceutical composition containing pregabalin with improved stability and method for preparing same | |
| GEP201706760B (en) | Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same | |
| EP3342414A4 (en) | MEANS FOR IMPROVING ATP IN CELLS | |
| HK1249129A1 (zh) | 用於細胞施予、保存、或培養的容器 | |
| EP3555108A4 (en) | MATERIAL FOR THE STORAGE AND DELIVERY OF HYDROGEN | |
| EP3020742A4 (en) | Trioxane composition and method for storing same | |
| SI3303320T1 (sl) | Nove heterociklične spojine, postopek za pripravo le-teh in farmacevtski sestavek vsebujoč le-te | |
| MX2018001221A (es) | Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla. | |
| MX2018001219A (es) | Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla. | |
| MX2018001222A (es) | Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla. | |
| MX2018001223A (es) | Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla. | |
| AU2016905200A0 (en) | Hydrogen storage and delivery material | |
| HK1224131A2 (zh) | 作能源儲存的組合物及其系統 | |
| GB2526399B (en) | Battery case for lead-acid battery, lead-acid battery using the battery case, and resin composition for the battery case | |
| AU2015901765A0 (en) | Improvements in container base |